- News article -

Customer success-story: Optomed secured 1,97 M€ EU funding for Smartscope-X – affordable, accessible and automatic screening for diabetic retinopathy

12 Oct 2017

In May, the Finnish medical technology company Optomed was granted 1,97 M€ from Horizon 2020 SME Phase 2 instrument under the topic Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well. The funding will help Optomed make their product Smartscope-X the leading solution for diabetic retinopathy screening, supporting the company’s vision to provide affordable eye screenings to everyone.

Diabetic retinopathy is the most frequent cause of preventable blindness in working-aged adults, affecting people with all types of diabetes. Visual impairment and blindness caused by diabetic retinopathy can be prevented through early and effective screening. Currently, screening is costly, time-consuming and needs to be done by an ophthalmologist. Optomed’s solution will allow patients to do the screenings automatically and get the diagnosis in real-time.

Optomed’s fully automated diabetic retinopathy screening solution consists of three main components: a low-cost handheld camera, an automated screening algorithm and a cloud service for eyeground images. As a low-cost and portable solution, Smartscope-X can also provide access to screening for example in developing countries.

Spinverse supported Optomed in project preparation, including help in defining the scope, matching the call and assisting in writing the proposal. After a positive decision from the EU Commission in May 2017, Spinverse supported Optomed in the project negotiation phase.

“The cooperation with Spinverse worked well. The applicant always has the main responsibility during the application process, but the support from Spinverse and their expertise on the application process helped us achieve the desired outcome,” says Seppo Kopsala, CEO of Optomed.

The project officially began in August. Currently, Optomed is working on product development related to the integration between the camera and the software as well as choosing subcontractors for the server solution. Next steps towards the commercialization of Smartscope-X include several clinical tests and commercial pilots in target countries during 2018–2019.

What can you achieve with EU funding? See how we have helped companies create success stories and  contact us to discuss your options.

Photo credit: Optomed

- News -

Relevant posts

CTO of the Year ctoeurope Spinverse News

Who should be the next CTO of the Year Europe?

10 Sep 2019

European innovators deserve to be celebrated for helping to solve some of the most pressing challenges of ou...

White Papers ecosystem Open Innovation

Key insights into building and leading open innovation ecosystems

9 Sep 2019

How to co-create and collaborate in complex and continuously changing environments? What are the cornerstone...

Client News EU funding sustainability

Accelerating biomass conversion technologies - Spinverse helped with 13 M€ EU grant

27 Aug 2019

Avantium N.V. with nine partners across Europe were awarded with a € 13 million grant from Horizon2020's S...

Innovation Challenge competition energy

Submit your idea to the Fingrid Radio Frequency Interference monitoring challenge

13 Aug 2019
EU funding Spinverse News

EU funding Webinar 14.8. – Great opportunity to boost your innovation

23 Jul 2019

Did you know there is still over 10 billion euros of EU funding available for the next year? And, this R&...

Innovation Challenge SME Spinverse News

Innovation Challenge as a springboard to success

17 Jul 2019

While Spinverse Innovation Challenge allows the large companies looking for new ideas to find truly out-of-t...